OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) IN PATIENTS WITH MYELOFIBROSIS (MF) EXPOSED TO JAK1/2 INHIBITORS

被引：0
|
作者：
Shanavas, M. [1 ]
Popat, U. [2 ]
Michaelis, L. C. [3 ]
Fauble, V. [4 ]
Mclornan, D. [5 ]
Klisovic, R. [6 ]
Mascarenhas, J. [7 ]
Tamari, R. [8 ]
Arcasoy, M. [9 ]
Davies, J. [10 ]
Gergis, U. [11 ]
Ukaegbu, O. [12 ]
Kamble, R. [13 ,14 ]
Storring, J. [15 ]
Majhail, N. S. [16 ]
Romee, R. [17 ]
Lew, J. [7 ]
Pagliuca, A. [5 ]
Vasu, S. [6 ]
Ernst, B. [4 ]
Atenafu, E. [1 ]
Hanif, A. [3 ]
Champlin, R. [2 ]
Hari, P. [2 ]
Gupta, V. [1 ]
机构：
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[3] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[4] Mayo Clin Arizona, Rochester, MN USA
[5] Kings Coll London, London, England
[6] Ohio State Univ, Columbus, OH 43210 USA
[7] Mt Sinai Med Ctr, New York, NY 10029 USA
[8] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[9] Duke Univ, Sch Med, Durham, NC 27706 USA
[10] Oxford Univ Hosp NHS Trust, Churchill Hosp, Oxford, England
[11] Weill Cornell Med Coll, New York, NY USA
[12] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[13] Baylor Coll Med, Houston, TX 77030 USA
[14] Houston Methodist Hosp, Houston, TX USA
[15] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
[16] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH 44195 USA
[17] Washington Univ, Sch Med, St Louis, MO USA
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S450
引用
收藏
页码：162 / 163
页数：2
相关论文
共 50 条
  • [1] Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib
    Jaekel, N.
    Behre, G.
    Behning, A.
    Wickenhauser, C.
    Lange, T.
    Niederwieser, D.
    Al-Ali, H. K.
    BONE MARROW TRANSPLANTATION, 2014, 49 (02) : 179 - 184
  • [2] Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib
    N Jaekel
    G Behre
    A Behning
    C Wickenhauser
    T Lange
    D Niederwieser
    H K Al-Ali
    Bone Marrow Transplantation, 2014, 49 : 179 - 184
  • [3] Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitors
    Gupta, Vikas
    Hari, Parameswaran
    Hoffman, Ronald
    BLOOD, 2012, 120 (07) : 1367 - 1379
  • [4] Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors.
    Shanavas, Mohamed
    Popat, Uday
    Michaelis, Laura C.
    Fauble, Veena
    McLornan, Donal
    Klisovic, Rebecca
    Mascarenhas, John
    Tamari, Roni
    Arcasoy, Murat O.
    Davies, James
    Gergis, Usama
    Ukaegbu, Oluchi C.
    Kamble, Rammurti T.
    Storring, John M.
    Majhail, Navneet S.
    Romee, Rizwan
    Verstovsek, Srdan
    Pagliuca, Antonio
    Vasu, Sumithira
    Ernst, Brenda
    Atenafu, Eshetu G.
    Hanif, Ahmad
    Champlin, Richard
    Hari, Paremeswaran
    Gupta, Vikas
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : 432 - 440
  • [5] The Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) and Treatment with Ruxolitinib on Survival in Patients with Myelofibrosis
    Jaekel, Nadja
    Wang, Song-Yau
    Krahl, Rainer
    Hubert, Karolin
    Schulze, Susann
    Stengel, Rayk
    Schneider, Melanie
    Roskos, Martin
    Niederwieser, Dietger
    Al-Ali, Haifa Kathrin
    BLOOD, 2015, 126 (23)
  • [6] Allogeneic hematopoietic cell transplantation for patients with myelofibrosis
    Zang, Dae Young
    Deeg, H. Joachim
    CURRENT OPINION IN HEMATOLOGY, 2009, 16 (02) : 140 - 146
  • [7] Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients with Calr-Mutated Myelofibrosis
    Boluda, Juan Carlos Hernandez
    Eikema, Dirk-Jan
    Erazo, Nadia
    Kroeger, Nicolaus
    Robin, Marie
    de Witte, Moniek
    Finke, Juergen
    Rambaldi, Alessandro
    Broers, Annoek E. C.
    Raida, Ludek
    Schaap, Nicolaas
    Chiusolo, Patrizia
    Verbeek, Mareike
    Choi, Goda
    Halaburda, Kazimierz
    Kulagin, Alexander D.
    Labussiere-Wallet, Helene
    Gedde-Dahl, Tobias
    Rabitsch, Werner
    Raj, Kavita
    Drozd-Sokolowska, Joanna
    Polverelli, Nicola
    Czerw, Tomasz
    Yakoub-Agha, Ibrahim
    McLornan, Donal P.
    BLOOD, 2022, 140 : 10608 - 10610
  • [8] Early Hepatotoxicity in Patients with Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)
    Robin, Marie
    Gras, Luuk
    Gagelmann, Nico
    Koster, Linda
    de Latour, Regis Peffault
    Van Gorkom, Gwendolyn
    Ganser, Arnold
    Itala-Remes, Maija
    Zuckerman, Tsila
    Beguin, Yves
    Schaap, Nicolaas
    Drozd-Sokolowska, Joanna
    Raj, Kavita
    Hayden, Patrick J.
    de Wreede, Liesbeth C.
    Czerw, Tomasz
    Hernandez Boluda, Juan Carlos
    Kroeger, Nicolaus
    Yakoub-agha, Ibrahim
    McLornan, Donal P.
    BLOOD, 2022, 140 : 7585 - 7586
  • [9] Allogeneic Stem Cell Transplantation in Patients with BCR-ABL-Negative Myeloproliferative Neoplasms Pretreated with JAK1/JAK2 Inhibitors
    Barabanshikova, Maria
    Morozova, Elena
    Moiseev, Ivan
    Vlasova, Julia
    Baykov, Vadim
    Ushal, Inna
    Rodionov, Gennadij
    Moiseev, Sergey
    Barkhatov, Ildar
    Afanasyeva, Ksenija
    Bondarenko, Sergey
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 402 - 403
  • [10] A CASE STUDY OF RESENSITIZATION TO RUXOLITINIB, A JAK1/JAK2 INHIBITOR, IN A PATIENT WITH MYELOFIBROSIS (MF)
    Gisslinger, H.
    Skrabs, C.
    Gisslinger, B.
    Schoder, R.
    Muellauer, L.
    Kralovics, R.
    HAEMATOLOGICA, 2013, 98 : 346 - 347
12345